These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11265126)

  • 21. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging.
    Nakayama M; Yamashita Y; Mitsuzaki K; Yi T; Arakawa A; Katahira K; Nakayama Y; Takahashi M
    J Magn Reson Imaging; 2000 Jun; 11(6):647-54. PubMed ID: 10862064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
    Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
    AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of dynamic MRI with superparamagnetic iron oxide (SH U 555 A): vascularity evaluation in hepatocellular carcinoma.
    Saito K; Hashimoto T; Kotake F; Nakamura H; Mizokami Y; Shimokobe K; Abe K
    Magn Reson Med Sci; 2002 Dec; 1(4):199-205. PubMed ID: 16082145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
    Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
    J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.
    Chen F; Ward J; Robinson PJ
    Magn Reson Imaging; 1999 May; 17(4):549-56. PubMed ID: 10231181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
    Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
    J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
    Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A
    J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
    Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
    J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
    Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J
    J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic characterization of focal hepatic lesions: role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo-planar sequence.
    Hori M; Murakami T; Kim T; Iannaccone R; Abe H; Onishi H; Tomoda K; Catalano C; Passariello R; Nakamura H
    J Magn Reson Imaging; 2006 Apr; 23(4):509-19. PubMed ID: 16523480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization.
    van Gansbeke D; Metens TM; Matos C; Nicaise N; Gay F; Raeymaekers H; Struyven J
    J Magn Reson Imaging; 1997; 7(3):482-9. PubMed ID: 9170031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
    Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN
    J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging.
    Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK
    Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
    Lee JM; Kim IH; Kwak HS; Youk JH; Han YM; Kim CS
    Korean J Radiol; 2003; 4(1):1-8. PubMed ID: 12679628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of SPIO particles for characterization of liver hemangiomas using MRI.
    Montet X; Lazeyras F; Howarth N; Mentha G; Rubbia-Brandt L; Becker CD; Vallee JP; Terrier F
    Abdom Imaging; 2004; 29(1):60-70. PubMed ID: 15160755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.